Home > Browse Reports > Biotechnology > Veterinary Health Markets

Report Description

Veterinary Health Markets
Publication Date: 21-AUG-07
Pages: 222
Study: TMRVET
Format/Price: PDF document / $3,400.00
   


Description:



View Sample PDF


Profound changes are happening in the animal health market. Pet owners in the United States are demanding more advanced and expensive treatments for companion animals, driving growth in the companion-animal sector. At the same time, concerns about livestock health care and feeding are driving changes in industrial animal husbandry. This TriMark Publications report offers a broad, yet detailed, overview of the shape of the veterinary health products market over the next several years. Examining both livestock and companion-animal markets. The overall market for veterinary therapeutics and diagnostic products has grown dramatically. This report analyzes the U.S. veterinary pharmaceuticals and diagnostics markets. The report outlines market size, market growth, forecasts, and competitive information. Focusing both on companion (pet) animal markets and agricultural livestock, the report examines the markets for pharmaceuticals, vaccines, diagnostics, and feed additives. The study reveals: the size of the markets for companion-animal products, broken down by type of animal (i.e., cats, dogs, small animals, etc.); size of the markets for livestock products; how the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) regulations impact these markets; the identity of the top market players, along with their market shares and future prospects; how the antibiotic feed additive controversy is influencing the agricultural market; and key players in the veterinary pharma and diagnostic markets.





Table of Contents:

  1. 1. Overview 6
  2. 1.1 Objective of Report 6
  3. 1.2 Scope of Report 6
  4. 1.3 Methodology 7
  5. 1.4 Executive Summary 8
  6. 2. Veterinary Biological Products 10
  7. 2.1 Overview of Health Products Market 10
  8. 2.1.1 World Products Markets 10
  9. 2.1.2 U.S. Animal Health Products Market 12
  10. 2.1.3 European Animal Health Markets 12
  11. 2.1.4 Asian Animal Health Products Markets 13
  12. 2.1.5 World Market Share 14
  13. 2.1.6 Common Animal Diseases 14
  14. 2.1.7 Companion Animals 38
  15. 2.2 Veterinary Vaccines 40
  16. 2.2.1 Major Canine Vaccines 42
  17. 2.2.2 Major Feline Vaccines 44
  18. 2.3 Agricultural Animals 46
  19. 2.3.1 Major Cattle Vaccines 47
  20. 2.3.2 Major Poultry Vaccines 53
  21. 2.3.3 Major Sheep Vaccines 58
  22. 2.3.4 Major Swine Vaccines 61
  23. 2.3.5 Horses 66
  24. 2.4 Trends in the Biologicals Market 68
  25. 2.5 Nutraceuticals 68
  26. 2.5.1 Nutraceutical Market for Companion Animals 69
  27. 2.6 OTC Animal Health Global Market Opportunity 69
  28. 3. Veterinary Pharmaceutical Products 71
  29. 3.1 Overview 71
  30. 3.1.1 Pharmaceutical Products for Dogs and Cats 76
  31. 3.1.1.1 Antiparasites 79
  32. 3.1.1.2 Antibiotics 80
  33. 3.1.1.3 Anti-Inflammatories 83
  34. 3.1.1.4 Chronic Care Products 86
  35. 3.1.1.5 Cardiovasculars 86
  36. 3.1.1.6 GI Products 87
  37. 3.1.1.7 Endocrine Products 87
  38. 3.1.1.8 Anti-Infectives 88
  39. 3.1.1.9 Behavior Modifiers 89
  40. 3.1.1.10 Anthelmimetics 90
  41. 3.1.1.11 Antifungals 91
  42. 3.1.2 Pharmaceutical Products for Agricultural Animals 91
  43. 3.1.2.1 Antiparasites 91
  44. 3.1.2.2 Antibiotics 92
  45. 3.1.2.3 Insecticides 93
  46. 3.2 Leading Products and Competitors 94
  47. 3.2.1 Elanco 94
  48. 3.2.2 Novartis 95
  49. 3.2.3 Alpharma 96
  50. 3.2.4 Wyeth 97
  51. 3.2.5 Pfizer Animal Health 97
  52. 3.3 Veterinary Pharmaceutical Market Trends 98
  53. 3.4 Companion-Animal Crossover Products 98
  54. 3.5 Generics in the Animal Health Sector 99
  55. 4. Veterinary Feed Additive Products 100
  56. 4.1 Overview 100
  57. 4.2 U.S. Feed Additives Market 102
  58. 4.3 Leading Feed Additives and Competitors 102
  59. 4.4 Feed Additives Market Trends 104
  60. 4.4.1 Livestock Performance Enhancers 104
  61. 4.5 Pet Food Additives and Contaminants 106
  62. 4.5.1 Pet Deaths 106
  63. 4.5.2 The FDA Response 106
  64. 5. Veterinary Diagnostic Test Products 107
  65. 5.1 Introduction 107
  66. 5.2 Veterinary Diagnostic Market Size and Growth Rates 108
  67. 5.2.1 Market Drivers 110
  68. 5.2.2 Immunodiagnostic and Nucleic Acid Testing Markets 111
  69. 5.2.2.1 Market Size and Growth 111
  70. 5.2.3 Technological Developments in the Diagnostic Industry 111
  71. 5.3 Competitive Situation 112
  72. 5.4 Estimate of Units Sold and Pricing 113
  73. 5.5 PCR Applications for Veterinary Use 113
  74. 5.6 Companion-Animal Diagnostics 117
  75. 5.6.1 Feline Leukemia Virus 117
  76. 5.7 Agricultural Animal Diagnostics 118
  77. 5.8 U.S. Diagnostic Test Market 119
  78. 5.9 Leading Competitors in Diagnostic Testing 120
  79. 5.10 Veterinary Diagnostic Market Trends 123
  80. 5.11 Collaborative Licensing 124
  81. 5.12 BSE Diagnostic Tests 124
  82. 5.13 West Nile Virus Diagnostic Tests 124
  83. 5.14 Avian Flu Diagnostic Tests 125
  84. 6. Overview of the Veterinary Health Market 126
  85. 6.1 Regulatory Environment 126
  86. 6.1.1 Regulation of Animal Health Products in the E.U. 127
  87. 6.1.2 Regulation of Animal Health Products in Japan 129
  88. 6.1.2.1 Regulatory Environment 129
  89. 6.1.2.2 Withdrawal Periods 130
  90. 6.1.2.3 Filing Procedures for New Animal Drug Applications 130
  91. 6.1.2.4 Use of Outdated Animal Studies 130
  92. 6.1.2.5 Brand-Specific Listing for Antimicrobial Antibiotic and Other Feed Additives 130
  93. 6.1.3 Proposed Regulation of Animal Antibiotics 130
  94. 6.2 The European Animal Health Industry 131
  95. 6.2.1 Trends Driving Demand 131
  96. 6.2.1.1 European, International and U.S. Oversight of Veterinary Medicines 131
  97. 6.2.1.2 Antibiotic Usage 132
  98. 6.3 Mergers and Acquisitions 132
  99. 6.4 New Product Launches 133
  100. 6.5 Bioterrorism and Foodborne Pathogens„oWHO Guidelines 134
  101. 6.6 Generic Products 135
  102. 7. Emerging Markets 137
  103. 7.1 Biotechnology and Veterinary Health 137
  104. 7.1.1 Biotechnology and Biologics 137
  105. 7.1.1.1 Recombinant DNA Vaccines 137
  106. 7.1.1.2 Plant-Derived Vaccines 137
  107. 7.1.2 DNA Probes 138
  108. 7.1.3 Biotechnology and Pharmaceuticals 138
  109. 7.1.3.1 Immune System Augmentation 138
  110. 7.1.3.2 Growth Enhancers 139
  111. 7.2 Impact of Genomics on Veterinary Health 139
  112. 7.2.1 Autosomal Dominant Traits 141
  113. 7.2.2 X-Linked Traits 142
  114. 7.2.3 Autosomal Recessive Traits 142
  115. 7.2.4 Current DNA Testing in Animals 144
  116. 7.2.5 Direct DNA Testing: Mutation-Based Tests 144
  117. 7.2.6 Indirect DNA Testing: Linkage-Based or Marker-Based Tests 145
  118. 7.3 Companion-Animal Markets 145
  119. 7.4 Alternative Medicine in Veterinary Practice 145
  120. 8. Company Profiles 146
  121. 8.1 Abaxis, Inc. 146
  122. 8.2 Abbott Laboratories 148
  123. 8.3 Adiagene 148
  124. 8.4 Agricultural Research Service 149
  125. 8.5 Alpharma, Inc. 149
  126. 8.6 Avian Biotech 153
  127. 8.7 BASF Agricultural Products and Nutrition 153
  128. 8.8 Bayer Animal Health 154
  129. 8.9 Biobest Diagnostics 155
  130. 8.10 BioVet, Inc. 155
  131. 8.11 Boehringer Ingelheim Corp. 156
  132. 8.12 Cypress Diagnostics 157
  133. 8.13 DayMoon Industries, Inc. 158
  134. 8.14 Dow AgroSciences LLC 159
  135. 8.15 Dupont Qualicon 159
  136. 8.16 Elanco Animal Health 160
  137. 8.17 Fort Dodge Animal Health 160
  138. 8.18 Gene Check, Inc. 161
  139. 8.19 Gene-Trak 161
  140. 8.20 Heska Animal Health 162
  141. 8.21 IDEXX Laboratories, Inc. 164
  142. 8.22 IGEN International, Inc. 167
  143. 8.23 IMC Global, Inc. 167
  144. 8.24 Intervet International 169
  145. 8.25 IVAX Corporation 169
  146. 8.26 Laboklin 170
  147. 8.27 Medigenomix GmbH 170
  148. 8.28 Merial Animal Health 170
  149. 8.29 Microbix Biosystems, Inc. 171
  150. 8.30 Monsanto 172
  151. 8.31 Novartis Animal Health 173
  152. 8.32 OptiGen 174
  153. 8.33 PE AgGen/Celera AgGen 175
  154. 8.34 PETCO Animal Supplies, Inc. 176
  155. 8.35 PetSmart, Inc. 176
  156. 8.36 Pfizer Animal Health 177
  157. 8.37 Roche Animal Nutrition and Health 182
  158. 8.38 Sanofi-Aventis 183
  159. 8.39 Schering-Plough Animal Health Corporation 184
  160. 8.40 Synbiotics Corporation 185
  161. 8.41 VCA Antech, Inc. 187
  162. 8.42 Virbac SA 188
  163. 8.43 Wyeth 189
  164. 9. Business Trends in the Industry 190
  165. 9.1 Animal Health Additive Growth Trends 190
  166. 9.2 Move to Complete Product Portfolio 190
  167. 9.3 Reduced Antibiotic Usage in Animal Feeds 190
  168. 9.4 European Animal Health Industry 190
  169. 9.5 Licensing and Partnership Opportunities in Animal Health R&D 191
  170. 10. Company Directory 192
  171. Appendix 1: Dosages for Selected Drugs Alphabetical Listing 195
  172. Appendix 2: Trade Names 208
  173. Appendix 3: Nomenclature 220
  174. INDEX OF FIGURES
  175. Figure 2.1: Worldwide Sales of Animal Health Products Market by Product Class, 2006 11
  176. Figure 2.2: Worldwide Animal Health Products Market by Region, 2006 11
  177. Figure 2.3: U.S. Companion Animal Healthcare Products Share of Overall Animal Health Product Sales, 2006 12
  178. Figure 3.1: Novartis Business Split 95
  179. Figure 3.2: Novartis Product Split 95
  180. Figure 3.3: Novartis Geographic Split 96
  181. Figure 4.1: Global Market for Livestock Performance Enhancers, 2006 105
  182. LIST OF TABLES
  183. Table 2.1: World Market for Animal Health Products, 2004-2012 10
  184. Table 2.2: Global Sales of Animal Health and Nutrition Products, 2004-2012 10
  185. Table 2.3: Worldwide Animal Health Products Market by Region, 2006 11
  186. Table 2.4: U.S. Animal Health Product Sales, 2005-2012 12
  187. Table 2.5: Japanese Animal Health Market, 2000-2012 13
  188. Table 2.6: Chinese Animal Health Products Market, 2005-2012 14
  189. Table 2.7: Worldwide Animal Health Product Sales for Leading Producers, 2006 14
  190. Table 2.8: List A Diseases 15
  191. Table 2.9: List B Diseases 15
  192. Table 2.10: Cattle Diseases 16
  193. Table 2.11: Sheep and Goat Diseases 16
  194. Table 2.12: Equine Diseases 17
  195. Table 2.13: Swine Diseases 17
  196. Table 2.14: Avian Diseases 17
  197. Table 2.15: Fish Diseases 18
  198. Table 2.16: Other Veterinary Diseases 18
  199. Table 2.17: Leading Companion-Animal Prescription Drugs by Sales, 2006 38
  200. Table 2.18: Worldwide Veterinary Vaccine Market, 2005-2012 41
  201. Table 2.19: U.S. Veterinary Vaccine Market, 2000-2008 41
  202. Table 2.20: Canine Vaccinations 43
  203. Table 2.21: Dog Vaccine Price List 44
  204. Table 2.22: Global Market for Nutraceutical in Companion Animals, 2005-2012 69
  205. Table 3.1: Veterinary Drugs Listed by Therapeutic Class 71
  206. Table 3.2: Animal Health Product Sales in the U.S., 2000-2008 75
  207. Table 3.3: Sales of Pharmaceutical Products for Animal Health in the U.S., 2000-2008 76
  208. Table 3.4: Number of Dogs in the U.S., 1996, 2001 and 2006 77
  209. Table 3.5: Number of Pet Dogs by Country 77
  210. Table 3.6: Number of Cats in the U.S., 1996, 2001 and 2006 77
  211. Table 3.7: Number of Pet Cats by Country 77
  212. Table 3.8: U.S. Spending on Pet Care, 1996, 2001 and 2006 78
  213. Table 3.9: American Veterinary Board Certified Diplomats 78
  214. Table 3.10: Companion-Animal Products in Excess of $ 1 Billion Sales 78
  215. Table 3.11: U.S. Antiparistic Animal Health Product Sales, 2005-2012 79
  216. Table 3.12: Worldwide Sales of Animal Health Antibiotics, 2005-2012 80
  217. Table 3.13: U.S. Volume of Animal Health Antibiotics Used, 2000-2006 81
  218. Table 3.14: U.S. Sales of Animal Health Antibiotics, 2005-2012 81
  219. Table 3.15: Common Veterinary Anti-Inflammatories 84
  220. Table 3.16: U.S. Pet Anti-Inflammatory Market, 2000-2009 84
  221. Table 3.17: Retail Pricing of Rimadyl 85
  222. Table 3.18: Etogesic Pricing 85
  223. Table 3.19: Bacterial and Protozoal Threats to Poultry 93
  224. Table 3.20: Bacterial and Protozoal Threats to Pigs 93
  225. Table 3.21: Elanco Veterinary Products Summary 94
  226. Table 3.22: Wyeth Fort Dodge Animal Health Products 97
  227. Table 4.1: Sales of Feed Additives for Animal Health in the U.S., 2001-2008 100
  228. Table 4.2: Feed Additives„oAntimicrobials and Growth Promotants 103
  229. Table 4.3: Feed Additives„oAnthelmintics 103
  230. Table 4.4: U.S. Sales of Animal Health Chemicals, 2001-2010 103
  231. Table 4.5: U.S. Beef Exports, 2001-2006 104
  232. Table 4.6: U.S. States Beef Production by State, 2003 104
  233. Table 4.7: Global Market for Livestock Performance Enhancers, 2004-2010 105
  234. Table 5.1: Veterinary Diagnostics World Market, 2005-2012 108
  235. Table 5.2: Veterinary Immunodiagnostic Testing World Markets, 2005-2012 111
  236. Table 7.1: Labs that Perform Canine DNA Testing 142
  237. Table 7.2: DNA (Mutation) Tests for Canine Inherited Diseases 143
  238. Table 7.3: DNA (Marker) Tests for Canine Inherited Diseases 143
  239. Table 8.1: Alpharma Revenue and Operating Income/Loss, 2001-2003 151
  240. Table 8.2: Alpharma Revenue and Operating Income/Loss and Discontinued Operations, 2004-2006 152
  241. Table 8.3: Pfizer Animal Health Products 178
  242. Table 8.4: Pfizer Products Patents 179
  243. Table 8.5: Key Pfizer Animal Health Products 181
  244. Table 8.6: Pfizer Livestock Products 182
  245. Table 8.7: Pfizer Equine Products 182
  246. Table 8.8: Pfizer Companion Animal Products 182
  247. Table 9.1: European Animal Health Market Sales, 2004-2010 191

Registration
Browse Reports
Search TriMark
Reading Room
My Account
View Cart
Home  |  Reports  |  Database Tables  |  Conferences  |  Contact Us  
     © 2008 TriMark Publications, LLC. All rights reserved.